NCT01924182 - Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Chronic Pain

Interventions

DEVICE

SynchroMed Infusion System and Intrathecal Morphine Sulfate

Following a successful test of Intrathecal Morphine Sulfate, subjects will undergo surgery to implant the drug pump (SynchroMed Infusion System) and spinal catheter. The pump will deliver morphine directly to the spinal cord for pain control.

OTHER

Conventional Medicine

Subjects will continue to use pain medications as prescribed by their doctor.

Trial Locations (6)

27103

The Center for Clinical Research, Winston-Salem

32806

Compass Research, Orlando

35209

Pain Management Services PC, Homewood

94558

Napa Pain Institute and Neurovations, Napa

94598

IPM Medical Group (Interventional Pain Medical Group), Walnut Creek

22908-0710

University of Virginia Pain Management Center, Charlottesville